Synapse Preservation to Counter Cognitive Decline

Minerve’s first-in-class approach focuses on blocking synaptic pruning reactivation in late-life, which is closely linked to brain atrophy and cognitive decline. By directly addressing this pathological pruning, Minerve’s therapies aim to safeguard synaptic integrity and prevent the progression of neurodegenerative diseases, offering a unique solution to a fundamental unmet need in CNS therapeutics.